[1] |
Alencar RC, Cobas RA, Gomes MB. Allergic reaction related to ramipril use: a case report[J]. Diabetol Metab Syndr, 2010, 2: 4. DOI: 10.1186/1758⁃5996⁃2⁃4.
|
[2] |
王冰丽. 卡托普利致剥脱性皮炎型[J]. 山东医药, 2007, 47(28): 63. DOI: 10.3969/j.issn.1002⁃266X.2007.28.100.
|
|
Wang BL. Exanthematous drug eruption due to captopril[J]. Shandong Med J, 2007, 47(28): 63. DOI: 10.3969/j.issn.1002⁃266X.2007.
|
[3] |
陈向前, 刘向农. 口服卡托普利致重症药疹合并药物性肝炎1例[J]. 福建医药杂志, 2004, 1(26): 162. DOI: 10.3969/j.issn.1002⁃2600.2004.01.148.
|
|
Chen XQ, Liu XN. A case of serious drug eruptions with hepatitis due to oral captopril[J]. Fujian Med J, 2004, 1(26): 162. DOI: 10.3969/j.issn.1002⁃2600.2004.01.148.
|
[4] |
Ozturk G, Turk BG, Senturk B, et al. Exanthematous drug eruption due to valsartan[J]. Cutan Ocul Toxicol, 2012, 31(4): 335⁃337. DOI:10.3109/15569527.2011.647179.
|
[5] |
Fessa C, Lim P, Kossard S, et al. Lichen planus⁃like drug eruptions due to beta⁃blockers: a case report and literature review[J]. Am J Clin Dermatol, 2012, 13(6): 417⁃421. DOI: 10.2165/11634590⁃000000000⁃00000.
|
[6] |
Joly P, Benoit⁃Corven C, Baricault S, et al. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case⁃control study[J]. J Invest Dermatol, 2007, 127(12): 2766⁃2771.
|
[7] |
陈颖, 刘茁, 计雄飞, 等. 尼群地平引起大疱性表皮松解型药疹1例[J]. 临床皮肤科杂志, 2008(11): 743. DOI: 10.3969/j.issn.1000⁃4963.2008.11.026.
|
|
Chen Y, Liu Z, Ji XF, et al. A case of drug eruption (bullous epidermolysis type) induced by nitrendipine[J]. J Clin Dermatol, 2008(11): 743. DOI: 10.3969/j.issn.1000⁃4963.2008.11.026.
|
[8] |
Rasmussen E, Mey K, Bygum A. Angiotensin⁃converting enzyme inhibitor⁃induced angioedema:a dangerous new epidemic[J]. Acta Derm Venereol, 2014, 94(3): 260⁃264. DOI: 10.2340/00015555⁃1760.
|
[9] |
Powell RJ, Leech SC, Till S, et al. BSACI guideline for the management of chronic urticaria and angioedema[J]. Clin Exp Allergy, 2015, 45(3): 547⁃565. DOI: 10.1111/cea.12494.
|
[10] |
Cilia LCA, Carter AM, Rice GI, et al. A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor⁃induced angioedema[J]. Hum Mutat, 2011, 32(11): 1326⁃1331. DOI: 10.1002/humu.21579.
|
[11] |
Basavaraj KH, Ashok NM, Rashmi R, et al. The role of drugs in the induction and/or exacerbation of psoriasis[J]. Int J Dermatol, 2010, 49(12): 1351⁃1361. DOI: 10.1111/j.1365⁃4632.2010.04570.x.
|
[12] |
Gin A, Gin D, Sinclair R. Metoprolol⁃induced psoriatic nail disease[J]. Australas J Dermatol, 2013, 54(1): 59⁃60. DOI: 10.1111/j.1440⁃0960.2012.00916.x.
|
[13] |
Kim GK, Del RJ. Drug⁃provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance[J]. J Clin Aesthet Dermatol, 2010, 3(1): 32⁃38.
|
[14] |
Wu S, Han J, Li W, et al. Hypertension, antihypertensive medi⁃cation use, and risk of psoriasis[J]. JAMA Dermatol, 2014, 150(9): 957⁃963. DOI: 10.1001/jamadermatol.2013.9957.
|
[15] |
Vena GA, Cassano N, Coco V, et al. Eczematous reactions due to angiotensin⁃converting enzyme inhibitors or angiotensin II receptor blockers[J]. Immunopharmacol Immunotoxicol, 2013, 35(3): 447⁃450. DOI: 10.3109/08923973.2013.797992.
|
[16] |
Landmesser U, Drexler H. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide [J]. J Hypertens Suppl, 2006, 24(1): S39⁃S43. DOI: 10.1097/01.hjh.0000220405.38622.23.
|
[17] |
Gruen AB, Zhou J, Morton KA, et al. Photodegraded nifedipine stimulates uptake and retention of iron in human epidermal keratinocytes [J]. J Invest Dermatol, 2001, 116(5): 774⁃777.
|
[18] |
Kanjanabuch P, Arporniem S, Thamrat S, et al. Mucous membrane pemphigoid in a patient with hypertension treated with atenolol: a case report[J]. J Med Case Rep, 2012, 6(10): 373. DOI: 10.1186/1752⁃1947⁃6⁃373.
|
[19] |
Stavropoulos PG, Soura E, Antoniou C. Drug⁃induced pemphigoid: a review of the literature[J]. J Eur Acad Dermatol Venereol, 2014, 28(9):1133⁃1140. DOI: 10.1111/jdv.12366.
|
[20] |
Baricevic M, Mravak Stipetic M, Situm M, et al. Oral bullous eruption after taking lisinopril⁃case report and literature review[J]. Wien Klin Wochenschr, 2013, 125(13⁃14): 408⁃411. DOI: 10.1007/s00508⁃013⁃0382⁃7.
|
[21] |
Adriano AR, Gomes NA, Hamester GR, et al. Pemphigus vegetans induced by use of enalapril[J]. An Bras Dermatol, 2011, 86(6): 1197⁃1200.
|
[22] |
Bae YI, Yun SJ, Lee SC, et al. Pemphigus foliaceus induced by an angiotensin II receptor blocker[J]. Clin Exp Dermatol, 2008, 33(6): 721⁃723. DOI: 10.1111/j.1365⁃2230.2008.02857.x.
|
[23] |
GangeRW, JonesEW. Bullous lichen planus caused by labetalol[J]. Br Med J, 1978, 1(6116): 816⁃817.
|
[24] |
Staughton R, Sutton R, Farrell M. beta⁃Blockers, autoimmunity, and rashes[J]. Lancet, 1980, 2(8194): 581.
|
[25] |
Marzano A, Vezzoli P, Crosti C. Drug⁃induced lupus: an update on its dermatologic aspects[J]. Lupus, 2009, 18(11): 935⁃940. DOI: 10.1177/0961203309106176.
|
[26] |
Marzano AV, Lazzari R, Polloni I, et al. Drug⁃induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart[J]. Br J Dermatol, 2011, 65(2): 335⁃341. DOI: 10.1111/j.1365⁃2133.2011.10397.x.
|
[27] |
Sawada Y, Yoshiki R, Kawakami C, et al. Valsartan⁃induced drug eruption followed by CD30+ pesudolymphomatous eruption[J]. Acta Derm Venereol, 2010, 90(5): 521⁃522. DOI: 10.2340/00015555⁃0695.
|
[28] |
Kabashima R, Orimo H, Hino R, et al. CD30⁃positive T⁃cell pseudolymphoma induced by amlodipine[J]. J Eur Acad Dermatol Venereol, 2008, 22(12): 1522⁃1524. DOI: 10.1111/j.1468⁃3083.2008.02671.x.
|
[29] |
Chan JC, Yap DY, Yeung CK. Hydralazine⁃induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis[J]. J Clin Pharm Ther, 2014, 39(3): 322⁃324. DOI: 10.1111/jcpt.12141.
|
[30] |
Barcik K, Protas⁃Drozd F, Weiss⁃Rostkowska W, et al. Acute generalised exanthematosus pustulosis (AGEP) due to diltiazem--a case report[J]. Kardiol Pol, 2009, 67(8): 887⁃891.
|
[31] |
Chaabane A, Fadhl NB, Chadly Z, et al. Captopril⁃induced DRESS: first reported case confirmed by patch test[J]. Dermatitis, 2013, 24(5): 255⁃257. DOI: 10.1097/DER.0b013e3182a5d86d.
|